ERYP Erytech Pharma S.A. ADRs

Erytech Pharma is a France based clinical-stage biopharmaceutical company. It is engaged conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ERYP.

$0.96  -0.08 (-7.43%)
As of 03/24/2023 16:30:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  France
IPO date:  07/05/2016
Outstanding shares:  31,018,553
Average volume:  4,560
Market cap:   $32,066,980
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%